Dr Wendy Ingram
Profiles

Dr Wendy Ingram

Trial Manager

Clinical Trials & Health Research - Institute of Translational & Stratified Medicine (Faculty of Medicine and Dentistry)

Role

Clinical Trials Manager for Peninsula Clinical Trials Unit

Qualifications

PhD Pharmacokinetic and pharmacodynamic modelling of subcutaneous apomorphine in the treatment of idiopathic Parkinson's disease


BSC (Hons) Biomedical Technology

Research interests

Prospective longitudinal study of multiple sclerosis in South West England


Randomised clinical trials

Key publications are highlighted

Journals
Articles
Ukoumunne OC, Vaidya B, Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A & Ingram W 2017 'A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study' BMJ Open 7, (3) e013519-e013519 , DOI PEARL
Ingram WM, Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A, Pinkney J & Ukoumunne O 2013 'A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)' BMJ Open 2013;doi:10.1136/bmjopen-2013-003396
Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A, Ingram W, Pinkney J & Ukoumunne OC 2013 'A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)' BMJ Open 3, (7) e003396-e003396 , DOI PEARL
Freeman J, Walters R, Ingram W, Slade A, Hobart J & Zajicek J 2013 'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures' Mult Scler 19, (12) 1632-1639 Author Site , DOI
Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C & Hunt SE 2011 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis' Nature 476, (7359) 214-219 , DOI PEARL
Zajicek JP, Ingram WM, Vickery J, Creanor S, Wright DE & Hobart JC 2010 'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort' BMC Neurol 10, Author Site , DOI PEARL
Ingram WM, Priston MJ & Sewell GJ 2006 'Improved assay for R(−)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease' Journal of Chromatography B 831, (1-2) 1-7 , DOI
Warner M, Baron RA, Ingram WM, Vickery PJ, Reilly S, Wright DE, Zajicek JP & Hobart JC 2006 'Does the GHQ-30 leave room for change?' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP 2006 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Ingram WM, Hobart JC, Reilly SM, Vickery PJ, Wright DE & Zajicek JP 2006 'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R, Ingram W, Warner M, Vickery PJ, Wright DE, Zajicek J & Hobart JC 2006 'Meaningless statistics and the illusion of fatigue' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Hobart, Riazi A, Styles IM & Thompson AJ 2005 'Getting the measure of spasticity in Multiple Sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS - 89)' Brain 129, (1) 224-234 , DOI
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ & Thompson AJ 2005 'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up' J Neurol Neurosurg Psychiatry 76, (12) 1664-1669 Author Site , DOI
Baron R, Zajicek J, Wright D, Vickery J, Ingram W & Hobart J 2005 'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?' Multiple Sclerosis 11, S68-S68
Hobart J, Riazi A, Thompson A, Styles I, Ingram W, Vickery J, Warner M, Fox P & Zajicek J 2005 'Getting the measure of spasticity in MS: the multiple sclerosis spasticity scale' Multiple Sclerosis 11, S104-S104
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP 2005 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of the Neurological Sciences 238, S229-S229
Baron R, Ingram W, Warner M, Vickery J, Wright D, Zajicek J & Hobart J 2005 'Meaningless statistics and the illusion of fatigue measurement' Multiple Sclerosis 11, S68-S68
Zajicek J, Fox R, Teare L, Sanders H, Wright D, Vickery J, Ingram W, Reilly S, Nunn A & Thompson A 2004 'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression' Journal of Neurology 251, 44-44
Ingram WM, Priston MJ & Sewell GJ 1999 'Dose optimisation for amorphine in Parkinson's disease: Pharmacokinetic-pharmacodynamic (PK-PD) studies' Journal of Pharmacy and Pharmacology 51, (SUPPL.)
Conference Papers
Warner M, Baron RA, Ingram WM, Vickery PJ, Reilly S, Wright DE, Zajicek JP & Hobart JC 2006 'Does the GHQ-30 leave room for change?' 134-134
Ingram WM, Hobart JC, Reilly SM, Vickery PJ, Wright DE & Zajicek JP 2006 'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis' 131-131